Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(3):235-236; doi:10.1093/jnci/dji037
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Grenader, T.
Right arrow Articles by Peretz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grenader, T.
Right arrow Articles by Peretz, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Metastatic Hormone-Refractory Prostate Cancer

Tal Grenader, Linda Shavit, Beatrice Uziely, Tamar Peretz

Affiliations of authors: Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel (TG, BU, TP); Department of Medicine, Sha'are Zedek Medical Center, Jerusalem, Israel (LS)

Correspondence to: Tal Grenader, MD, Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel 91120 (e-mail: talgrenader65@hotmail.com).

The first 10% of the full text of this article appears below.

We read with great interest the paper by Saad et al. (1), which reported that zoledronic acid effectively reduces metastasis related bone pain and skeletal complications in patients with metastatic prostate cancer. We are particularly interested in the zoledronic acid-induced elevation in serum parathyroid hormone (PTH) levels that was initially reported . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?